In another research, Lunit presented new data confirming the predictive power of AI-based spatial profiling in MET-mutated ...

Researchers have utilized ultrastructure expansion microscopy to reveal more about the cytoskeletal characteristics of the ...

Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TT A multiplex QIF assay was optimized on tissue ...

CelLBxHealth presents proof-of-concept study using Roche Tissue Diagnostics' workflow at world-leading drug development ...

Parsortix platform shown to be compatible with the Roche BenchMark ULTRA automated staining system, with initial study of three key drug targets: HER2 (breast), TROP2 (lung) and PSMA ...

Biocare Medical, a global leader in immunohistochemistry instrumentation, antibodies and reagents, and Hamamatsu Corporation, a worldwide innovator in imaging technologies, today announced a strategic ...